Authorised Phase II and Phase III (Integrated) bariatric surgery

Evaluation of the effect of Opioid-Free Anesthesia on oxygenation in bariatric surgery

EU CTIS ID: 2024-519722-20-00

What this study is testing

To evaluate the effect of Opioid-Free Anesthesia on the Arterial Oxygen Pressure/Inspired Fraction of Oxygen (PaO2/FiO2) ratio during the first 6 postoperative hours in comparison with conventional anesthesia.

  • Phase II and Phase III (Integrated)

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

  • Patients aged 18 or over
  • Patients pending laparoscopic vertical gastrectomy for bariatric surgery.
  • Give informed consent

You likely can't join if

  • Advanced heart block (grade 2 or 3 in the absence of a pacemaker).
  • Preoperative renal dysfunction, estimated through the preoperative GFR rate (creatinine clearance < 50ml/min).
  • Liver failure
  • Hypersensitivity to gabapentin, lidocaine, dexmedetomidine, ketamine, NSAIDs, paracetamol or Magnesium Sulfate.
  • Myasthenia gravis

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18-64 years. The study team makes the final eligibility decision.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.